文章摘要
霍增辉.药品管理法修订背景下医疗机构制剂监管创新与完善[J].中国药事,2020,34(5):514-519
药品管理法修订背景下医疗机构制剂监管创新与完善
Innovation and Improvement of the Supervision of Pharmaceutical Preparations in Medical Institutions in the Context of Drug Administration Law Revision
投稿时间:2020-03-31  
DOI:10.16153/j.1002-7777.2020.05.003
中文关键词: 医疗机构制剂  监管  创新  完善
英文关键词: pharmaceutical preparations in medical institutions  supervision  innovation  improvement
基金项目:
作者单位
霍增辉 北京中医药大学, 北京 100029 
摘要点击次数: 80
全文下载次数: 44
中文摘要:
      目的: 分析修订的《药品管理法》在医疗机构制剂监管上的创新,为医疗机构制剂监管完善提供建议。方法: 查阅相关文献和法规,结合我国医疗机构及医疗机构制剂行业现状,对医疗机构制剂监管进行评析。结果: 修订后的《药品管理法》的实施对医疗机构制剂发展将产生积极影响,其内容涵盖简化审批程序、修改调剂使用原则、细化和强化过程监管、完善法律责任。结论: 修订的《药品管理法》在医疗机构制剂监管方面有创新性的制度设计,但与之衔接的下位规章需进一步修订、完善。
英文摘要:
      Objective: To explore the innovative features of the revised Drug Administration Law in the supervision of pharmaceutical preparations of medical institutions and provide insights for the improvement of the supervision of pharmaceutical preparations in medical institutions. Methods: By reviewing the relevant literatures and investigating the current situation of pharmaceutical preparations in medical institutions, supervision and administration of pharmaceutical preparations in medical institutions were discussed and assessed. Results: Implementation of the revised Drug Administration Law will have a positive impact on the development of pharmaceutical preparations in medical institutions, including simplification of the approval process, revision of the principles for the use of dispensers, refinement and strengthening of process regulation and improvement of legal responsibilities. Conclusion: Revised Drug Administration Law has various innovative features for the supervision of pharmaceutical preparations in medical institutions, but the supporting documents and guidelines shall be further revised and improved accordingly.
查看全文   查看/发表评论  下载PDF阅读器
关闭